Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01ZZG
|
||||
Former ID |
DIB008717
|
||||
Drug Name |
INV-311
|
||||
Synonyms |
Myeloperoxidase inhibitors (vascular/inflammatory disease), InVasc Therapeutics
|
||||
Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Investigative | [543711] | ||
Company |
InVasc Therapeutics Inc
|
||||
Target and Pathway | |||||
Target(s) | Myeloperoxidase | Target Info | Inhibitor | [543711] | |
KEGG Pathway | Phagosome | ||||
Transcriptional misregulation in cancer | |||||
Pathway Interaction Database | C-MYB transcription factor network | ||||
IL23-mediated signaling events | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.